Women with dense or homogeneous dense breast tissue should consider an alternate form of breast cancer screening beyond traditional mammography.
Category: Cancer (Page 9)
As part of its ongoing mission to expand and optimize its clinical research infrastructure and provide patients access to the most advanced cancer treatment and prevention strategies available, UVA Cancer Center welcomes two world-class clinicians and researchers to grow its bone marrow transplant program.
A UVA study revealed that most women don’t know that having dense breast tissue increases their risk for cancer and reduces a mammogram’s ability to detect it.
An expert in immunotherapy, Lawrence G. Lum, MD, DSc joins UVA Cancer Center as the scientific director of bone marrow transplantation. One of Lum’s priorities is pioneering a new method of activating the body’s own T cells to target tumor cells.
The Center to Advance Palliative Care (CAPC) has designated UVA Health System as a Palliative Care Learning Center (PCLC) for their success in providing comprehensive palliative care in the ambulatory setting.
High-grade glioma patients at UVA now have the opportunity to participate in Toca 5, an international clinical trial of a new, virus-based procedure that activates therapeutics selectively within the brain tumor, leading to fewer side effects.
One of the most widely read stories among radiation oncologists this year is one announcing a prostate cancer discovery by UVA radiation oncologist Timothy Showalter, MD.
UVA is the only health system in Virginia named to the 2015 list of 100 hospitals and health systems with great oncology programs, published by Becker’s Hospital Review.
UVA is stepping up its efforts to implement strategies for early diagnosis and is setting the standard for surgical outcomes nationwide.
Precision Breast IORT is a unique form of IORT developed at UVA — now being examined in a Phase II clinical trial — that incorporates CT imaging and high-dose rate (HDR) brachytherapy.